Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

• by Conor B. Driscoll, Jordan M. Rich, Christopher Yang, Joseph Nicolas, Dylan Isaacson, Philip Silberman, Xinlei Mi, Sai Kaushik Shankar Ramesh Kumar, Hui Zhang, Steven Belknap, William H. Temps, Edward M. Schaeffer, Shilajit D. Kundu

• February 26, 2026

Medicaid Expansion and Mortality Among Patients With Colorectal Cancer

• by Oluwasegun Akinyemi, Oladayo Oyebanji, Babawale Oluborode, Bolarinwa Akinwumi, Fadeke Ogunyankin, Kakra Hughes, Terrence Fullum, Quyen Chu, Surya Nalamati, Marwan Abouljoud, Christine Nembhard, Craig Reickert

• September 18, 2026

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors

• by Renato Cuocolo, Andrea Ponsiglione, Georgios Agrotis, Tristan Barrett, Giorgio Brembilla, Iztok Caglic, Hanna Falińska, Charlie Alexander Hamm, Emanuele Messina, Tobias Penzkofer, Raphaële Renard-Penna, Olivier Rouvière, Luca Russo, Evis Sala, Johannes Uhlig, Anwar R. Padhani, Maarten de Rooij

• September 18, 2026

Roving Reporter Asks: How Is Cell and Gene Therapy Manufacturing Becoming More Scalable?

IBTV speaks with industry leaders at ASGCT 2026 about the technologies, processes, and manufacturing strategies helping advanced therapies progress toward commercial scale

• September 18, 2026

• 2 min